Van ECK Associates Corp Has $13.64 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)

Van ECK Associates Corp lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 8.6% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 57,679 shares of the medical research company’s stock after selling 5,418 shares during the period. Van ECK Associates […]

Related Keywords

Canada ,United States ,Williamd Barbo ,Asia Pacific ,Robertw Baird ,Shannonm Parisotto ,Charles River Laboratories International Profile ,Venturi Wealth Management ,Jpmorgan Chase Co ,Associates Corp ,Operose Advisors ,Citigroup ,Research Models ,Visionpoint Advisory Group ,Manufacturing Solutions ,Quarter For Charles River Laboratories International ,Headlands Technologies ,Insider Transactions At Charles River Laboratories International ,Provence Wealth Management Group ,Securities Exchange Commission ,Charles River Laboratories International Stock ,Charles River Laboratories International ,Charles River Laboratories International Inc ,Free Report ,Point Advisory Group ,Wealth Management ,River Laboratories International ,Get Free Report ,Charles River Laboratories ,Exchange Commission ,Safety Assessment ,Visit Holdingschannel ,Charles River Laboratories International Daily ,Nyse Crl ,Crl ,Medical ,15986410 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,